Last updated: 2026-09-16 09:45:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
enVVeno Medical Corporation (NVNO) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $9.41, with a market capitalisation of $6.52M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8.67 to $35.70. This page covers its latest market performance, valuation, price trends and company information.
$6.52M | |
$9.60 | |
$374.50 | |
$8.67 | |
$9.38 | |
29.57K | |
20.99K | |
-- | |
$35.70 | |
$8.67 | |
-- | |
-- |
enVVeno Medical Corporation (NVNO) is trading at $11.06 in pre-market trading as of 2026-09-15 20:11:00, up 17.91% ($1.68) from the previous close of $9.38
Pre-market trading shows how investors are pricing NVNO before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, enVVeno Medical Corporation (NVNO) moved from $11.44 to $9.41, representing a decline of 17.78% ($2.03).
The stock traded between $9.07 and $11.82 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 48.30 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 2.7%
NVNO is currently trading at $9.41, placing it 2.7% of the way from its 52-week low of $8.67 to its 52-week high of $35.70. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 33 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of enVVeno Medical Corporation (NVNO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.